Dr. W. Mark Boomer, MD

Expert Publications

• Anticoagulation and prothrombin time ratios.

Media Releases

Get to know Pulmonologist Dr. W. Mark Boomer, who serves patients in Tulsa, Oklahoma.

A fellowship-trained specialist in the field of pulmonology, Dr. Boomer opened RespirCare Open Access in Tulsa, Oklahoma. He treats acute and chronic breathing problems, including COPD, asthma, bronchitis, pneumonia, emphysema, pulmonary and cystic fibrosis.

RespirCare is a novel concept, treating acute and chronic breathing problems involving a wide spectrum of respiratory issues, from minor to the most severe. The goal is to provide rapid care for a patient when they may not be able to access their primary care physician or specialist. RespirCare offers walk-in treatments every day of the week.

Back in the early days of his academic career, Dr. Boomer graduated with his medical degree from the University of Oklahoma College of Medicine in 1986. He then performed his residency at the same educational venue in 1989, and his fellowship in critical care medicine at the University of Texas Health Science Center at San Antonio in 1992.

Holding triple board certification, the doctor is board-certified in internal medicine, pulmonology disease, and critical care medicine by the American Board of Internal Medicine (ABIM). The ABIM is a physician-led, non-profit, independent evaluation organization driven by doctors who want to achieve higher standards for better care in a rapidly changing world.

Practicing medicine in the state of Oklahoma, Dr. Boomer is affiliated with Integris Grove Hospital, Saint Francis Hospital, Ascension Oklahoma St. John Broken Arrow, Jack C. Montgomery Veterans Affairs Medical Center, and Muscogee Creek Nation Medical Center.

Pulmonology is a medical specialty that deals with diseases involving the respiratory tract. A pulmonologist is an internal medicine physician who specializes in preventing, diagnosing, and treating conditions and diseases that affect the lungs, bronchial tubes, and the respiratory system, including the nose, pharynx, and throat.

As a testament to his success, Dr. Boomer is the recipient of Patients’ Choice Award (2020), On-Time Doctor Award (2020), and Compassionate Doctor Recognition (2020).

Recommended Articles

• Staying Healthy as an Adult Living with Cystic Fibrosis

  Cystic fibrosis is a lifelong condition that begins at birth and slowly progresses throughout a person’s life. It is among the most difficult chronic illnesses to treat, manage, and survive. Despite this, the field of cystic fibrosis has made leaps and strides in the last fifty years, more than...

• 32-year-old with Cystic Fibrosis Raises Millions for Research

  32-year old Emily Kramer-Golinkoff has accomplished more in her life than most people can say. Though she was diagnosed with a life-long debilitating disease as an infant, she has refused to let the fate she was dealt with drag her down. This young woman is the founder of a non-profit called Emily's...

• 5 Tips on Living with Pleurisy

  What is pleurisy?Pleurisy, also called as pleuritis, is the inflammation of the pleural membranes lining your lungs. These double-membraned pleura are important because they protect and lubricate your lungs as you breathe in and out. The small amount of fluid in the pleural cavity helps the two...

• Pink Puffer and Blue Bloater: What Are They?

  No, they are not names of mythical characters from a fantasy novel. Far from it, really! As charming as their names sound, "pink puffer" is not the furry little pink creature that you are tempted to imagine nor is the "blue bloater" a big and friendly blue giant. What do these terms mean exactly?To...

• Everything About the Mycoplasma pneumoniae Infection

  Mycoplasma pneumoniae is a bacterium that causes an infectious respiratory infection. Mycoplasma pneumoniae can spread very easily from person to person via airborne droplets.Lung infections caused by M. pneumoniae can become very serious affecting your heart and nervous system if left...

• New Cystic Fibrosis Treatment Shows Promise for those with a Specific Gene Mutation

  The data released on July 18th from three clinical trials conducted by Vertex Pharmaceuticals revealed promising results. The drugs that were tested in these trials are three different triple combination regimes that are designed to treat the underlying cause of cystic fibrosis in patients with the...